文献速递肿瘤 PET/CT神经核医学

延迟[18F]-FDG PET显像提高脑转移瘤复发与放射性坏死鉴别诊断效能及可重复性

Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis.
PubMed 文献 · Clin Nucl Med · 2022-06-11

本研究回顾性纳入2015至2020年间3个中心46例患者的48个病灶,比较标准、延迟及双时间点[18F]-FDG PET对脑转移瘤复发与放射性坏死的鉴别效能。延迟显像的ROC曲线下面积(0.88)高于标准(0.69)和双时间点显像(0.77),观察者间一致性也更高(κ=0.83)。结论认为延迟[18F]-FDG PET是MRI结论不明确时准确可靠的替代方法。

要点

  • 延迟[18F]-FDG PET鉴别脑转移复发与放射性坏死的AUC为0.88,高于标准(0.69)和双时间点(0.77)。
  • 延迟显像观察者间一致性几乎完美(κ=0.83),标准(κ=0.48)和双时间点(κ=0.61)为中等。
  • 延迟[18F]-FDG PET可作为脑立体定向放疗后MRI结论不明确时准确可靠的替代方法。

核心结论

  • 延迟[18F]-FDG PET显像是脑立体定向放疗后MRI结论不明确时鉴别转移复发与放射性坏死的准确可靠替代方法。

研究设计与样本

  • 回顾性纳入2015至2020年间3个中心因MRI结论不明确而转诊行脑[18F]-FDG PET的连续患者。
  • 共分析46例患者的48个病灶,由两名核医学医师独立判读标准(视觉)、延迟(视觉)和双时间点(半定量)图像,意见不一致时进行裁决。
  • 最终诊断经组织学或6个月MRI随访确认。

主要发现

  • 原发肿瘤多位于肺(57%)和乳腺(23%),放疗与PET的中位间隔为15.7个月。
  • 48个病灶中最终诊断为肿瘤复发24个(50%),其中19个(40%)经组织学确认。
  • 延迟显像AUC为0.88(95%CI 0.75-0.95),高于标准显像0.69(95%CI 0.54-0.81;P=0.0014)和双时间点显像0.77(95%CI 0.63-0.88;P=0.045)。
  • 观察者间一致性延迟显像κ=0.83(几乎完美),标准显像κ=0.48(中等),双时间点显像κ=0.61(中等)。

临床怎么用

  • 作者认为,脑立体定向放疗后MRI结论不明确时,延迟[18F]-FDG PET显像可作为鉴别转移复发与放射性坏死的准确可靠替代方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Differentiating brain metastasis recurrence from radiation necrosis can be challenging during MRI follow-up after stereotactic radiotherapy. [ 18 F]-FDG is the most available PET tracer, but standard images performed 30 to 60 minutes postinjection provide insufficient accuracy. We compared the diagnostic performance and interobserver agreement of [ 18 F]-FDG PET with delayed images (4-5 hours postinjection) with the ones provided by standard and dual-time-point imaging. METHODS: Consecutive patients referred for brain [ 18 F]-FDG PET after inconclusive MRI were retrospectively included between 2015 and 2020 in 3 centers. Two independent nuclear medicine physicians interpreted standard (visually), delayed (visually), and dual-time-point (semiquantitatively) images, respectively. Adjudication was applied in case of discrepancy. The final diagnosis was confirmed histologically or after 6 months of MRI follow-up. Areas under the receiver operating characteristic curves were pairwise compared. RESULTS: Forty-eight lesions from 46 patients were analyzed. Primary tumors were mostly located in the lungs (57%) and breast (23%). The median delay between radiotherapy and PET was 15.7 months. The final diagnosis was tumor recurrence in 24 of 48 lesions (50%), with histological confirmation in 19 of 48 lesions (40%). Delayed images provided a larger area under the receiver operating characteristic curve (0.88; 95% confidence interval [CI], 0.75-0.95) than both standard (0.69; 95% CI, 0.54-0.81; P = 0.0014) and dual-time-point imaging (0.77; 95% CI, 0.63-0.88; P = 0.045), respectively. Interobserver agreement was almost perfect with delayed images ( κ = 0.83), whereas it was moderate with both standard ( κ = 0.48) and dual-time-point images ( κ = 0.61). CONCLUSIONS: [ 18 F]-FDG PET with delayed images is an accurate and reliable alternative to differentiate metastasis recurrence from radiation necrosis in case of inconclusive MRI after brain stereotactic radiotherapy.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Otman H, Farce J, Meneret P, et al. Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis. Clin Nucl Med. 2022. PMID: 35695724. doi:10.1097/RLU.0000000000004305

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。